Variant · Snv
CCND1 P287T
CI-VAR-00003331Explore in graph →NP_444284.1:p.Pro287ThrNM_053056.3:c.859C>ACIViC 3571
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 12955092
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Unmapped disease1unmapped disease | ||||||||
| CCND1 P287T | (functional) | Functional | D | Supports Gain Of Function | 1 | submitted | EID9781A series of 60 endometrioid endometrial carcinomas were tested for CCND1 expression and amplification. Two samples with CCND1 expression measured via IHC were shown to have somatic mutations (P287S an… (full text at CIViC) PMID 12955092 · Moreno-Bueno et al., 2003 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available